Last updated on May 2019

Online Automated Self-Hypnosis Program

Brief description of study

After developing professional quality materials (audio) for an inexpensive automated self-hypnosis intervention program for treating smoking cessation, researchers aim to gain qualitative reviews of this program, and test its initial feasibility and effects on smoking cessation.

Detailed Study Description

The investigators are interested in recruiting individuals who report that they smoke cigarettes daily, are motivated to make a serious attempt at quitting, and are willing to try to use the hypnosis intervention and provide feedback regarding their experience with the intervention.

The intervention would be pre-recorded and programmed to be an interactive hypnotic tool. It will be delivered through Amazon's Alexa device. The participants will be provided with the Alexa Dot device if they already do not possess one. Alexa Dot is a device sold by Amazon and widely used by consumers. What will be specific to this pilot is the interactive nature of the program that has been developed using the "skills beta testing tool" by Amazon.

Potential participants will be recruited through websites and social media such as Facebook, flyers and by study Investigator, Dr. David Spiegel (or a member of his staff) who will propose the possibility of participation in the pilot study to patients seen at the clinics who may be eligible; he will also invite his psychiatrist colleagues to do the same for their patients. If the patients indicate that they are interested, they will be contacted by a research coordinator who is a member of Dr. Spiegel's staff. The coordinator will provide them with information about the pilot study, answer their questions, and determine whether the patient is eligible for the study. Eligible participants will be 18 years or older, able to read and understand English, and have a desire to quit smoking. Once found eligible, participants will pay one visit to the lab for about 1 hour, where they will be guided through the online auditory intervention by Dr. Spiegel (or a member of his staff), undergo hypnotizability testing, and complete brief questionnaires. This will take approximately one hour and will take place at The Center on Stress and Health. After the lab visit participants will continue using the intervention at home as needed. Furthermore, participants will be taking an at-home 10-15 minute survey at baseline, and then 1, 3, 6, 12 and 24-month follow-ups

Clinical Study Identifier: NCT03931772

Find a site near you

Start Over

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.